Priscilla Kasenchak - 14 Apr 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Accounting Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
4
Filing time
18 Apr 2023, 16:46:24 UTC
Previous filing
05 Oct 2022
Next filing
25 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +4,393 +131% $0.000000 7,745 14 Apr 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +7,595 $0.000000 7,595 14 Apr 2023 Common Stock 7,595 $28.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2 Includes restricted stock units.
F3 Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

Remarks:

Exhibit List: Ex.24 - Power of Attorney